Category: AI

Time, date and format Date: Thursday 26 May, 2022 12pm PT Location: Breakout room to be confirmed Overview Delivered as part of AIMed’s Global Summit, this focus group discussion aims to explore how radiologists, cardiologists, radiology business leaders, and healthcare IT executives approach AI in medical imaging, in particular: What clinical and business challenges are…

Time, date and format Date: Wednesday 25 May, 2022 12pm PT Location: Breakout room to be confirmed Overview Moderated by Kieran Anderson, Group Publisher of Applied Radiology, this focus group aims to explore how radiologists, radiology business leaders, and healthcare IT executives are approaching the evaluation and selection of AI. Topics of discussion will include:…

What initially sparked your interest in medicine, specifically radiation oncology?  My initial interest in medicine grew from a deep desire to help cure my grandmother and other ill people as a very young child. This passion continues to motivate my pursuits in clinical care and research. As I explored different areas of medicine, I found…

CMR is one of the most powerful diagnostic tools in modern medicine and can provide highly reliable and actionable information for diagnosis and treatment across the spectrum of cardiovascular diseases. The high pace of technical advancements has led to a continuous expansion of the diagnostic capabilities and indications for CMR. This report provides a contemporary…

Guerbet’s Jared Houk on the evolution of medical imaging, the impact of AI, and the importance of clinical engagement. You have worked in medical imaging for the majority of your career. How have you seen the sector evolve over that time?   I have witnessed the medical community really embrace AI applications in recent years. When…

The AI-driven HART CVE blood test has been demonstrated to be highly accurate in determining whether a person with diabetes will have a heart attack or major cardiac event within the next year. Data presented at the recent American College of Cardiology (ACC) Scientific Sessions suggests the HART CVE blood test significantly improves risk classification…

You have enjoyed a varied career working for both large enterprise and small startups across IT, automotive, education, fintech and real estate amongst others. What led you to focus on digital diagnostics? We started up a fintech company in Luxembourg in 2014, but my oldest kids wanted to come home after a year to graduate…

“The works and customs of mankind do not seem to be very suitable material to which to apply scientific induction.” Alan Turing, progenitor of artificial intelligence For this AIMed publication of the week, we would like to introduce this commentary in Lancet Digital Health. The authors first discuss the obvious observation of this domain: interest…

Hartford HealthCare, a comprehensive and integrated healthcare system with more than 400 locations serving more than 17,000 people daily, and Ibex Medical Analytics, a pioneer in AI-powered cancer diagnostics, and have announced a clinical research study involving Ibex’s Galen™ Breast, an AI solution helping physicians deliver high-quality diagnosis and improved care for breast cancer patients.…

Courtesy of our partner Guerbet, we have two scholarship opportunities available for the ABAIM review course. How to apply? Potential scholars are asked to submit answers to the following questions (200-400 words per question) by Friday 29th April. What has your experience been of data science education within medicine? How does medical education need to…

“Many people who try to do big bold things in the world find out it’s not about the money or the technology: It’s about the regulatory hurdles that will try and stop you.” Peter Diamandis, Greek American physician and entrepreneur Introduction  While the artificial intelligence methodologies and tools in clinical medicine and healthcare are on…

Delayed and missed follow-up on incidental diagnostic imaging findings is one of the most prolific problems in healthcare, harming millions of patients across the country and driving up costs. In the USA, hospitals and health systems spend an estimated $43 million annually to settle lawsuits for missed follow-up on lung findings alone. “This problem is…